Why stock-market bulls can’t ignore rising COVID cases despite vaccine optimism

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 69 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 97%

United States News News

United States United States Latest News,United States United States Headlines

There's good news on the vaccine front, but what about stimulus talks? U.S. stocks could falter if politicians can’t come up with a post-election deal on another round of aid spending to shore up a bruised economy, some investors fear.

Progress toward a vaccine for COVID-19 is undeniably good news, but U.S. stocks could falter if politicians can’t come up with a post-election deal on another round of aid spending to shore up a bruised economy, some investors fear.

The focus in markets early this week turned to vaccine prospects after Pfizer Inc. PFE, -2.46% and Germany-based BioNTech SE BNTX, -7.14% early Monday announced their COVID-19 candidate was more than 90% effective in preventing infections. Analysts said some of the vaccine-inspired optimism seen earlier in the week was being overshadowed by the continued spread of the virus.

Investors, in the run-up to the election, were paying close attention to fiscal stimulus prospects as fraught negotiations between the Trump administration and House Democrats remained stalled. And even had their been a breakthrough, Senate Republicans were signaling resistance to the multi-trillion dollar packages being considered by the White House and Democratic lawmakers.

“Although there is still some near-term risk of increased government-imposed lockdowns due to the weather and the lag between development and broad distribution of a vaccine, the promise of a highly effective vaccine significantly reduces the need for a large phase four stimulus bill,” said Steven Ricchiuto, U.S. chief economist at Mizuho Securities U.S.A., in a note.

“We continue to believe that another package is needed to bridge the gap as we move through the tough winter months,” said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors, in a note.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

The whole socialist post-election agenda exposed

Unlimited QE I’ll keep buying calls

Are you looking for stocks? Our Ai stock analyst implies that there will be a positive trend in the future and the $OLL shares might be good for investing for making money. Since this share has a positive outlook we recommend it as a part in your portfolio

Chart's and more for $OLL🚀 OpenLearning $OLL Reported nothing but growth in the economic and pandemic crisis, $OLL should keep growing quite well⏳

good luck

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax Covid vaccine highly effective against severe Covid: companyUS biotech firm Novavax's Covid-19 vaccine was shown to be 100 percent protective against severe cases of the disease, including hospitalization and death, the company said Thursday following trials.
Source: YahooNews - 🏆 380. / 59 Read more »